1. Home
  2. EEFT vs VRDN Comparison

EEFT vs VRDN Comparison

Compare EEFT & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euronet Worldwide Inc.

EEFT

Euronet Worldwide Inc.

HOLD

Current Price

$70.95

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$15.16

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEFT
VRDN
Founded
1994
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.7B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
EEFT
VRDN
Price
$70.95
$15.16
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$96.00
$36.00
AVG Volume (30 Days)
530.9K
3.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
6.05
N/A
EPS
6.84
N/A
Revenue
$4,244,200,000.00
$5,706,000.00
Revenue This Year
$8.27
$28.34
Revenue Next Year
$6.03
$235.57
P/E Ratio
$10.31
N/A
Revenue Growth
6.38
N/A
52 Week Low
$63.73
$11.76
52 Week High
$114.25
$34.29

Technical Indicators

Market Signals
Indicator
EEFT
VRDN
Relative Strength Index (RSI) 57.08 25.82
Support Level $68.24 $13.59
Resistance Level $75.93 $19.03
Average True Range (ATR) 2.48 1.31
MACD 0.66 -0.56
Stochastic Oscillator 93.33 11.93

Price Performance

Historical Comparison
EEFT
VRDN

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: